← feed

Is NCT02558140 results overdue?

Yes — results are overdue. Primary completion was 2017-11-06; the FDAAA-801 reporting deadline (2018-11-06) passed 2784 days ago and no results are posted on ClinicalTrials.gov.

A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT IDNCT02558140 ↗
SponsorHoffmann-La Roche (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-11-06 (ACTUAL)
Reporting deadline2018-11-06 (completion + 365d)
Days overdue2784
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 30881f34242bf1d6… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02558140. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →